Answers are grounded in this paper and cite their sources.
To the Editor: We appreciate Restelli et al1's efforts in exploring an innovative approach to reducing healthcare-associated infections by integrating a 405-nm blue light system in a neurosurgical setting. Their prospective observational cohort study provides crucial clinical insight into the role of violet-blue light as a supplementary antimicrobial measure alongside conventional infection control protocols. The results showing a significant reduction in wound infections (10.4 vs 41.1 per 10 000 DoH, P = .001) and environmental contamination (plates with <25 CFU/plate: 68.3% vs 42.3% at 5 months, P = .001) are noteworthy.1 These findings are especially relevant in neurosurgical wards where patients are highly susceptible to infections due to complex procedures and prolonged hospital stays.2,3 Environmental contamination is critical to nosocomial infections, particularly in surgical and intensive care units.4,5 By reducing colony-forming units (CFUs) on surfaces and in the air, violet-blue light could break pathogenic organisms' transmission chain. Previous in vitro studies have established the antimicrobial effectiveness of 405-nm light against various pathogens through mechanisms involving reactive oxygen species generation and biofilm disruption.6-8 The INTEGRALIS® system employed in this study was designed with efficacy and user comfort. It transitions between DAY and NIGHT modes based on occupancy and lighting needs.1 Its compliance with safety standards further supports its feasibility in clinical practice.9 However, as the authors acknowledge, the nonrandomized design and inability to blind staff introduce a risk of performance and selection bias.1 These limitations may have influenced infection outcomes due to subconscious behavior changes among healthcare workers. Nonetheless, it is notable that surgeries in the blue light ward were of longer duration, a factor generally associated with increased infection risk.10 Despite this, the infection rate was significantly lower in the blue light ward, adding weight to the observed results. We also acknowledge the importance of assessing user satisfaction. Although some participants reported minor issues such as glare or altered depth perception, overall acceptance of the system was positive, with no serious adverse events.1 This user-centric approach is crucial for future scalability and acceptance across departments. There is a clear need for continued investigation through multicenter randomized trials to confirm these findings and assess long-term impacts, cost-effectiveness, and applicability in various hospital environments, including intensive care units and transplant units.11,12 Maintaining sterility in the operating theater depends heavily on proper instrument sterilization and the strict adherence of staff to aseptic practices. Environmental controls, such as 405-nm blue light systems, provide protection by continuously reducing microbial presence on surfaces and in the air. These systems serve as effective adjuncts to established infection control measures but not replacements for them.12 In conclusion, Restelli et al's study contributes valuable data on the real-world implementation of continuous, passive disinfection technology. The application of antimicrobial blue light holds promise as a complement to standard infection control practices, particularly in high-risk surgical settings.
No takes yet. Share an insight, caveat, or question.
Azhar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: